Silver Cross Pharmaceuticals Llp - Due diligence report

A 360° intelligence report on Silver Cross Pharmaceuticals Llp: trust score, financial health, credit view, compliance, directors, growth an…

2013-12-10 Bangalore, Karnataka Active
Connect MCP
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Silver Cross Pharmaceuticals Llp — 360° Intelligence Report

Generated from MCA filings & public records
57/100
Trust Score
Moderate

Silver Cross Pharmaceuticals Llp is assessed as Moderate with a Trust Score of 57/100. Silver Cross Pharmaceuticals Llp is an active limited liability partnership incorporated in 2013, operating in the Pharma sector. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and high financial risk profile.

Report generated on 14 Oct 2026 from the latest processed filings. Silver Cross Pharmaceuticals Llp snapshot & full profile →

Financial Health › Caution
Overall Assessment CautionWeakNeutralGoodStrong Good
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
57/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
75/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
25/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
60/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreModerate
50/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
50/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
50/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 60/100 Moderate
  • No open charges - unencumbered balance sheet.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 75/100 Low Risk
  • Company status is Active as per MCA.
  • Last balance sheet is for Mar 2023 - filings overdue.
05

Director Intelligence

Stability score: 50/100
NameDIN / PANDesignationAppointedTenureDIN status
AKASH UTTAM JAIN 01234567 Director 01/04/2018 6 yrs Approved
UTTAM KUMAR PUKHARAJ JAIN 01234567 Director 01/04/2018 6 yrs Approved
  • 2 directors on the board.
  • AKASH UTTAM JAIN has DIN status "Deactivated due to non-filing of DIR-3 KYC".
  • Stable board - no exits in 3 years.
06

Ownership & Group Intelligence

Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 50 · Distress 50
Growth signals & trust indicators
Operating for 12+ years.
Distress signals & risk flags
Revenue declined year-on-year.
Losses deepening year-on-year.
Statutory filings appear overdue.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence62/100
Review suggested
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 3 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment53/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance record supports lending.
Investor view43/100
Limited indicators at present
Growth quality and scalability through an investor lens.
  • No clear growth signals in the filed years.
  • Margin and return trends computable from filings.
  • Management churn warrants questions.
09

MCA Filings & Events Timeline

Latest 8 events
14 May 2023
Director ceased
AKASH UTTAM JAIN
Director ceased
UTTAM KUMAR PUKHARAJ JAIN
31 Mar 2023
Last AGM held
Annual general meeting
Latest balance sheet
Filed with ROC
01 Apr 2022
Director appointed
AKASH UTTAM JAIN (Designated Partner)
Director appointed
UTTAM KUMAR PUKHARAJ JAIN (Designated Partner)
22 May 2015
Director ceased
VISHAL SUBHAS CHAND PIPADA
10 Dec 2013
Incorporated
Registered with Roc Bangalore
10

Key Observations

Auto-generated from the data above
Compliance record is strong - status, filings and flags are clean.
2 active director(s) / partner(s); review board churn before relying on management continuity.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Metonym Power Source Private Limited U74999KA2017PTC108888 Bangaluru, Karnataka
Sti Engineers Private Limited U45203KA2014PTC075696 Bangaluru, Karnataka
Sadruta Consultants Private Limited U74140KA2008PTC045235 Bangaluru, Karnataka
Chalana Media Private Limited U30007KA2002PTC029999 Bangaluru, Karnataka
UCPRO CONSULTANTS LLP AAN-9308 Bangalore, Karnataka
Delightrix Technologies Private Limited U73200KA2023PTC174498 Bangaluru, Karnataka
Ramba Technologies Private Limited U74900KA2011PTC058201 Bangalore, Karnataka
Msquare Krishi Adhik Private Limited U01403KA2011PTC058290 Bangaluru, Karnataka
Swiss Medisciences Private Limited U46497KA2024PTC196079 Bangaluru, Karnataka
Fqo Technology Private Limited U72900KA2019PTC120936 Bangaluru, Karnataka
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Silver Cross Pharmaceuticals Llp before audits and certifications: compliance score 75/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Silver Cross Pharmaceuticals Llp: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 60/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Limited indicators at present. Growth score 50/100, margin trends, ownership structure and peer set for Silver Cross Pharmaceuticals Llp - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Review suggested. Trust score 57/100, distress signals and MSME payment-delay disclosures - know whether Silver Cross Pharmaceuticals Llp pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Silver Cross Pharmaceuticals Llp - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Silver Cross Pharmaceuticals Llp an active company?

Silver Cross Pharmaceuticals Llp has MCA status “Active” with a compliance score of 75/100 (Low Risk).

Is Silver Cross Pharmaceuticals Llp financially healthy?

Silver Cross Pharmaceuticals Llp has a Financial Health Score of 25/100 (Caution Indicated) based on its filed financial statements.

Should I do business with Silver Cross Pharmaceuticals Llp?

Its overall Trust Score is 57/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Silver Cross Pharmaceuticals Llp?

See the directors and ownership sections above for board and shareholding detail. 2 active director(s) are on record.

Does Silver Cross Pharmaceuticals Llp have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Silver Cross Pharmaceuticals Llp up to date with its ROC filings?

Last balance sheet is for Mar 2023 - filings overdue. Overall compliance score: 75/100 (Low Risk).

Is it risky to lend to Silver Cross Pharmaceuticals Llp?

Its Credit Risk Score is 60/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.